Stony Brook University, Stony Brook, New York, USA.
University of North Texas, Denton, Texas, USA.
Psychol Med. 2022 Jul;52(9):1666-1678. doi: 10.1017/S0033291722001301. Epub 2022 Jun 2.
The Hierarchical Taxonomy of Psychopathology (HiTOP) has emerged out of the quantitative approach to psychiatric nosology. This approach identifies psychopathology constructs based on patterns of co-variation among signs and symptoms. The initial HiTOP model, which was published in 2017, is based on a large literature that spans decades of research. HiTOP is a living model that undergoes revision as new data become available. Here we discuss advantages and practical considerations of using this system in psychiatric practice and research. We especially highlight limitations of HiTOP and ongoing efforts to address them. We describe differences and similarities between HiTOP and existing diagnostic systems. Next, we review the types of evidence that informed development of HiTOP, including populations in which it has been studied and data on its validity. The paper also describes how HiTOP can facilitate research on genetic and environmental causes of psychopathology as well as the search for neurobiologic mechanisms and novel treatments. Furthermore, we consider implications for public health programs and prevention of mental disorders. We also review data on clinical utility and illustrate clinical application of HiTOP. Importantly, the model is based on measures and practices that are already used widely in clinical settings. HiTOP offers a way to organize and formalize these techniques. This model already can contribute to progress in psychiatry and complement traditional nosologies. Moreover, HiTOP seeks to facilitate research on linkages between phenotypes and biological processes, which may enable construction of a system that encompasses both biomarkers and precise clinical description.
精神病理学的层次分类(HiTOP)是从精神病学分类的定量方法中发展而来的。这种方法根据症状和体征的共变模式来确定精神病理学的结构。最初的 HiTOP 模型于 2017 年发表,它基于跨越数十年研究的大量文献。HiTOP 是一个不断发展的模型,随着新数据的出现,它会不断修订。在这里,我们讨论了在精神病学实践和研究中使用该系统的优势和实际考虑因素。我们特别强调了 HiTOP 的局限性以及正在努力解决这些问题的情况。我们描述了 HiTOP 与现有诊断系统之间的差异和相似之处。接下来,我们回顾了开发 HiTOP 的证据类型,包括已经对其进行研究的人群以及有关其有效性的数据。本文还描述了 HiTOP 如何促进精神病理学的遗传和环境原因的研究,以及寻找神经生物学机制和新的治疗方法。此外,我们还考虑了对公共卫生计划和预防精神障碍的影响。我们还回顾了关于临床实用性的数据,并举例说明了 HiTOP 的临床应用。重要的是,该模型基于已经广泛应用于临床环境的措施和实践。HiTOP 提供了一种组织和形式化这些技术的方法。该模型已经可以为精神病学的发展做出贡献,并补充传统的分类学。此外,HiTOP 旨在促进表型和生物过程之间联系的研究,这可能使构建一个包含生物标志物和精确临床描述的系统成为可能。